Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Price, P. A.
Right arrow Articles by Williamson, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, P. A.
Right arrow Articles by Williamson, M. K.

© 2001 The American Society for Nutritional Sciences J. Nutr. 131:2910-2915, November 2001


Nutrient Interactions and Toxicity

The Amino Bisphosphonate Ibandronate Prevents Vitamin D Toxicity and Inhibits Vitamin D-Induced Calcification of Arteries, Cartilage, Lungs and Kidneys in Rats1

Paul A. Price2, Jessica R. Buckley and Matthew K. Williamson

Division of Biology, University of California, San Diego, La Jolla, CA 92093-0368

2To whom correspondence should be addressed. E-mail: pprice{at}ucsd.edu

ABSTRACT

Experiments were carried out to determine whether the doses of the amino bisphosphonate ibandronate that inhibit bone resorption inhibit soft tissue calcification and death in rats treated with a toxic dose of vitamin D. These studies were prompted by the recent discovery that ibandronate doses that inhibit bone resorption potently inhibit artery calcification induced by treatment with the vitamin K antagonist warfarin. All 16 rats treated with the toxic dose of vitamin D (12.5 mg cholecalciferol · kg-1) died by d 6 after the first vitamin D injection (median survival: 4.5 d), whereas the 12 rats treated with vitamin D plus ibandronate (0.25 mg · kg-1 · d-1) were alive and in good health at d 10. Rats treated with vitamin D alone and examined at d 4 had extensive Alizarin red staining for calcification in the aorta, the carotid, hepatic, mesenteric, renal and femoral arteries, kidneys and lungs, whereas rats treated with vitamin D plus ibandronate had no evidence for calcification at any of these tissues when examined at d 7 and 10. Ibandronate treatment also inhibited the dramatic increase in the levels of calcium and phosphate seen in the abdominal aorta, kidneys, lungs and trachea of the vitamin D-treated rats (P < 0.001). Serum calcium levels were, however, not different in rats treated with vitamin D alone (3.4 ± 0.2 mmol · L-1) and in rats treated with vitamin D plus ibandronate (3.5 ± 0.2 mmol · L-1). Treatment with vitamin D alone increased levels of matrix Gla protein, an inhibitor of soft tissue calcification, in the arteries, kidneys, lungs and trachea by 10- to 100-fold, and ibandronate treatment prevented this increase. The importance of these studies in the rat model is that they identify a class of drugs in current clinical use that can be used to treat patients with vitamin D toxicity and that they identify the dose of the drug that is predicted to be effective, namely the dose that inhibits bone resorption. Because there is no other known treatment for vitamin D toxicity, there would seem to be good reason to try bisphosphonates such as ibandronate in future studies aimed at treating patients who have been exposed to toxic levels of vitamin D.


KEY WORDS: • rats • warfarin • vitamin K • vitamin D • calcification • matrix Gla protein




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. A. Price, W. Si Chan, D. M. Jolson, and M. K. Williamson
The Elastic Lamellae of Devitalized Arteries Calcify When Incubated in Serum: Evidence for a Serum Calcification Factor
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. Y. Qunibi
Reducing the Burden of Cardiovascular Calcification in Patients with Chronic Kidney Disease
J. Am. Soc. Nephrol., November 1, 2005; 16(11_suppl_2): S95 - S102.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Endocr. Rev., August 1, 2004; 25(4): 629 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Price, M. K. Williamson, T. M. T. Nguyen, and T. N. Than
Serum Levels of the Fetuin-Mineral Complex Correlate with Artery Calcification in the Rat
J. Biol. Chem., January 16, 2004; 279(3): 1594 - 1600.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. A. Price, H. H. June, J. R. Buckley, and M. K. Williamson
SB 242784, a Selective Inhibitor of the Osteoclastic V-H+-ATPase, Inhibits Arterial Calcification in the Rat
Circ. Res., September 20, 2002; 91(6): 547 - 552.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]